Results 181 to 190 of about 23,134,989 (378)

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

open access: yesMolecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche   +8 more
wiley   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

open access: yesMolecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva   +5 more
wiley   +1 more source

THE SULFUR DISTRIBUTION IN PROTEINS

open access: hybrid, 1936
Harry D. Baernstein
openalex   +1 more source

Confidence Limits for the Indirect Effect: Distribution of the Product and Resampling Methods

open access: yesMultivariate Behavioral Research, 2004
D. Mackinnon   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy